HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency Mar 3, 2021
NAI500 Special Coverage: With Global CBD Legislations Solidifying, is the Industry at a Tipping Point for Investors? Mar 2, 2021 Cannabis, Life Science
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility Feb 26, 2021 Cannabis, Life Science
Healthcare Roundup – FDA says COVID-19 vaccines targeting variants won’t need lengthy trials; Recreational marijuana use officially legalized in New Jersey Feb 23, 2021 Life Science
Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify Feb 17, 2021 Life Science
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York Feb 17, 2021 Life Science
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva Feb 16, 2021 Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% Feb 12, 2021 Life Science
Healthcare Roundup – Merck and Teva in talks to join COVID-19 vaccine production, Aurora Cannabis shares up after FQ2 revenue rides high on medical cannabis strength Feb 11, 2021 Life Science
Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial Feb 10, 2021 Life Science
Healthcare Roundup – Bristol Myers announce new late-stage data for Opdivo/ Cabometyx combo in kidney cancer; Merck antiviral molnupiravir effective in preventing COVID-19 in lung tissue Feb 10, 2021 Life Science
HempFusion’s Chief Marketing Officer, Ms. Ola Lessard, Elected President of The U.S. Hemp Roundtable for Second Consecutive Term Feb 9, 2021 Life Science
Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU Feb 8, 2021 Life Science
Healthcare Roundup – Clover shares close up nearly 6% after Chamath Palihapitiya rebukes Hindenburg report; Bristol Myers Squibb wins FDA approval for lymphoma treatment Breyanzi Feb 5, 2021 Life Science
Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably Feb 4, 2021 Life Science
Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s Feb 4, 2021 Life Science
